A review of the use of in silico methods to predict the chemistry of molecular initiating events related to drug toxicity

Bibliography

• Kalgutkar AS, Didiuk MT. Structural alerts, reactive metabolites, and protein covalent binding: how reliable are these attributes as predictors of drug toxicity? Chem Biodivers 2009;6:2115-37
   PubMed Web of Science ®Google Scholar
• Kar S, Roy K. Development and validation of a robust QSAR model for prediction of carcinogenicity of drugs. Indian J Biochem Biophys 2011;48:111-22
   PubMed Web of Science ®Google Scholar
• Restrepo G, Basak SC, Mills D. Comparison of qsars and characterisation of structural basis of bioactivity using partial order theory and formal concept analysis: a case study with mutagenicity. Curr Comput Aided Drug 2011;7:109-21
   PubMed Web of Science ®Google Scholar
• Contrera JF. Improved in silico prediciton of carcinogenic potency (TD50) and the risk specific dose (RSD) adjusted Threshold of Toxicological Concern (TTC) for genotoxic chemicals and pharmaceutical impurities. Regul Toxicol Pharmacol 2011;59:133-41
   PubMed Web of Science ®Google Scholar
• Nakayama S, Atsumi R, Takakusa H, A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding. Drug Metab Dispos 2009;37:1970-7
   PubMed Web of Science ®Google Scholar
• Bessems JGM, Vermeulen NPE. Paracetamol (Acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol 2001;31:55-138
   PubMed Web of Science ®Google Scholar
• Bauman JN, Kelly JM, Tripathy S, Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 fraction. Chem Res Toxicol 2009;22:332-40
   PubMed Web of Science ®Google Scholar
• Evans DC, Watt AP, Nicoll-Griffith DA, Baille TA. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem Res Toxicol 2004;17:3-16
   PubMed Web of Science ®Google Scholar
• Srivastava A, Maggs JL, Antoine DJ, Role of reactive metabolites in drug-induced hepatotoxicity. In: Uetrecht JP, editor. Adverse Drug Reactions, Handbook of Experimental Pharmacology. Volume 196 Springer; Berlin: 2010
   Google Scholar
• Park BK, Boobis AR, Clarke S, Managing the challenge of chemically reactive metabolites in drug development. Nat Rev Drug Discov 2011;10:292-306
   PubMed Web of Science ®Google Scholar
• Gan J, Raun Q, He B, In vitro screening of 50 highly prescribed drugs for thiol adduct formation – Comparison of potential for drug-induced toxicity and extent of adduct formation. Chem Res Toxicol 2009;22:690-8
   PubMed Web of Science ®Google Scholar
• Kalgutkar AS, Soglia JR. Minimising the potential for metabolic activation in drug discovery. Expert Opin Drug Metab 2005;1:91-142
   PubMedGoogle Scholar
• Nakayama S, Atsumi R, Takakusa H, A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding. Drug Metab Dispos 2009;37:1970-7
   PubMed Web of Science ®Google Scholar
• Regan SL, Maggs JL, Hammond TG, Acyl glucuronides: the good, the bad and the ugly. Biopharm Drug Dispos 2010;31:367-95
   PubMed Web of Science ®Google Scholar
• Schultz TW. Adverse outcome pathways: a way of linking chemical structure to in vivo toxicological hazards. In: Cronin MTD, Madden JC, editors. In Silico Toxicology. RCS; Cambridge: 2010
   Google Scholar
• Kenna JG. Immunoallergic drug-induced hepatitis: lessons from halothane. J Hepatol 1997;26(Suppl 1):5-12
   PubMedGoogle Scholar
• Villeneuve DL, Garcia-Reyero N. Predictive ecotoxicology in the 21st century. Environ Toxicol Chem 2011;30:1-8
   PubMed Web of Science ®Google Scholar
• Ankley GT, Bennett RS, Erickson RJ, Adverse outcome pathways: a conceptual framework to support ecotoxicology and risk assessment. Environ Toxicol Chem 2010;29:730-41
   PubMed Web of Science ®Google Scholar
• Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005;4:489-99
   PubMed Web of Science ®Google Scholar
• Baillie TA. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. Chem Res Toxicol 2008;21:129-37
   PubMed Web of Science ®Google Scholar
• Vonk JA, Benigni R, Hewitt M, European Union OSIRIS integrated project workshop report: the use of mechanisms and modes of toxic action in integrated testing strategies. Altern Lab Anim 2009;37:547-56
   PubMedGoogle Scholar
• Matthews EJ, Kruhlak NL, Benz RD, Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: part C: use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities. Regul Toxicol Pharmacol 2009;54:43-65
   PubMed Web of Science ®Google Scholar
• Singh J, Petter RC, Baillie TA, Whitty A. The resurgence of covalent drugs. Nat Rev Drug Discov 2011;10:301-17
   Google Scholar
• Wen B, Fitch WL. Analytical strategies for the screening and evaluation of chemically reactive drug metabolites. Expert Opin Drug Metab 2009;5:39-55
   PubMed Web of Science ®Google Scholar
• Nelson SD. Metabolic activation and drug toxicity. J Med Chem 1982;25:753-65
   PubMed Web of Science ®Google Scholar
• Josephy PD. The molecular toxicology of acetaminophen. Drug Metab Rev 2005;37:581-94
   PubMed Web of Science ®Google Scholar
• Hinson JA, Pumford NR, Roberts DW. Mechanisms of acetaminophen toxicity: immunochemical detection of drug-protein adducts. Drug Metab Rev 1995;27:73-92
   PubMed Web of Science ®Google Scholar
• Obach RS, Kalgutkar AS, Soglia JR, Zhao SX. Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose. Chem Res Toxicol 2008;21:1814-22
   PubMed Web of Science ®Google Scholar
• Kalgutkar AS, Gardner I, Obach RS, A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab 2005;6:161-225
   PubMed Web of Science ®Google Scholar
• Cohen SD, Pumford NR, Khairallah EA, Selective protein covalent binding and target organ toxicity. Toxicol Appl Pharmacol 1997;143:1-12
   PubMed Web of Science ®Google Scholar
• Jaeschke H, Gores GJ, Cederbaum AI, Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166-76
   PubMed Web of Science ®Google Scholar
• Tang W, Lu AYH. Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical resaerch perspective. Drug Metab Rev 2010;42:225-49
   PubMed Web of Science ®Google Scholar
• Dragovic S, Boerma JS, van Bergen L, Role of human glutathione s-transferases in the inactivation of reactive metabolites of clozapine. Chem Res Toxicol 2010;23:1467-76
   PubMed Web of Science ®Google Scholar
• Moloney MG. Structure and Reactivity in Organic Chemistry. Blackwell Publishing; Oxford: 2008
   Google Scholar
• Enoch SJ, Roberts DW, Cronin MTD. Mechanistic category formation for the prediction of respiratory sensitization. Chem Res Toxicol 2010;23:1547-55
   PubMed Web of Science ®Google Scholar
• Zhou S, Chan E, Duan W, Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug Metab Rev 2005;1:41-213
   Google Scholar
• Schultz TW, Rogers K, Aptula AO. Read-across to rank skin sensitisation potential: subcategories for the Michael acceptor domain. Contact Dermatitis 2009;60:21-31
   PubMed Web of Science ®Google Scholar
• Ashby J, Tennant RW. Chemical structure, Salmonella mutagenicity and extent carcinogenicity as indicators of genotoxic carcinogenesis amoung 222 chemicals tested in rodents by the US NCI/NTP. Mutat Res 1988;204:17-115
   PubMed Web of Science ®Google Scholar
• Benigni R, Bossa C. Structure alerts for carcinogenicity, and the Salmonella assay system: a novel insight through the chemical relational databases technology. Mutat Res 2008;659:248-61
   PubMed Web of Science ®Google Scholar
• Gerner I, Barratt MD, Zinke S, Development and prevalidation of a list of structure-toxicity relationship rules to be used in expert systems for prediction of the skin-sensitising properties of chemicals. Altern Lab Anim 2004;32:487-509
   PubMed Web of Science ®Google Scholar
• Zinke S, Gerner I, Schlede E. Evaluation of a rule base for identifying contact allergens by using a regulatory database: comparison of data on chemicals notified in the European Union with “Structural Alerts” used in the DEREK expert system. Altern Lab Anim 2002;30:285-98
   PubMed Web of Science ®Google Scholar
• Enoch SJ, Madden JC, Cronin MTD. Identification of mechanism of toxic action for skin sensitisation using a SMARTS pattern based approach. SAR QSAR Environ Res 2008;19:555-78
   PubMed Web of Science ®Google Scholar
• Weininger D. SMILES. A chemical language and information-system. 1. Introduction to methodology and encoding rules. J Chem Inf Comp Sci 1988;28:31-6
   Google Scholar
• Enoch SJ, Cronin MTD, Ellison CM. The use of a chemistry-based profiler for covalent DNA binding in the development of chemical categories for read-across for genotoxicity. Altern Lab Anim 2011; In press
   PubMed Web of Science ®Google Scholar
• Enoch SJ, Cronin MTD. A review of the electrophilic reaction chemistry involved in covalent DNA binding. Crit Rev Toxicol 2010;40:728-48
   PubMed Web of Science ®Google Scholar
• Enoch SJ, Cronin MTD. A review of the electrophilic reaction chemistry involved in covalent protein binding relevant to toxicity. Crit Rev Toxicol 2011;41:783-802
   PubMed Web of Science ®Google Scholar
• Aptula AO, Roberts DW. Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity. Chem Res Toxicol 2006;19:1097-105
   PubMed Web of Science ®Google Scholar
• Roberts DW, Patlewicz G, Kern PS, Mechanistic applicability domain classification of a local lymph node dataset for skin sensitisation. Chem Res Toxicol 2007;20:1019-30
   PubMed Web of Science ®Google Scholar
• Enoch SJ, Roberts DW, Cronin MTD. Electrophilic reaction chemistry of low molecular weight respiratory sensitisers. Chem Res Toxicol 2009;22:1447-53
   PubMed Web of Science ®Google Scholar
• Enoch SJ, Cronin MTD, Schultz TW, Madden JC. Quantitative and mechanistic read across for predicting the skin sensitisation potential of alkenes acting via Michael addition. Chem Res Toxicol 2008;21:513-20
   PubMed Web of Science ®Google Scholar
• Schultz TW, Ralston KE, Roberts DW, Structure-activity relationships for abiotic thiol reactivity and aquatic toxicity of halo-substituted carbonyl compounds. SAR QSAR Environ Res 2007;18:21-9
   PubMed Web of Science ®Google Scholar
• Benigni R, Bossa C. Structure alerts for carcinogenicity, and the Salmonella assay system: a novel insight through the chemical relational databases technology. Mutat Res 2008;659:248-61
   PubMed Web of Science ®Google Scholar
• Benigni R, Netzeva TI, Benfenati E, The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens. J Environ Sci Health C 2007;25:53-97
   Web of Science ®Google Scholar
• Kirkman SK, Zhang MY, Horwatt PM, Scatina J. Isolation and identification of brofenac glucoside from rat bile. Drug Metab Dispos 1998;26:720-3
   PubMed Web of Science ®Google Scholar
• Kovacic P, Jacintho JD. Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr Med Chem 2001;8:773-96
   PubMed Web of Science ®Google Scholar
• Roy K, Mitra I. Advances in quantitative structure-activity relationship models of antioxidants. Expert Opin Drug Discov 2009;4:1157-75
   PubMed Web of Science ®Google Scholar
• Smith MT. Mechanisms of triglitazone hepatotoxicity. Chem Res Toxicol 2003;16:679-87
   PubMed Web of Science ®Google Scholar
• Murray AR, Kisin E, Castranova V, Phenol-induced in vivo oxidative stress in skin: evidence for enhanced free radical generation, thiol oxidation, and antioxidnat depletion. Chem Res Toxicol 2007;20:1769-77
   PubMed Web of Science ®Google Scholar
• O'Brien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact 1991;80:1-41
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes CJ, Moncol J, Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1-40
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84
   PubMed Web of Science ®Google Scholar
• Anderson N, Borlak J. Drug-induced phospholipidosis. FEBS Lett 2006;580:5533-40
   PubMed Web of Science ®Google Scholar
• Reasor MJ, Kacew S. Drug-induced phospholipidosis: are there functional consequences? Exp Biol Med 2001;226:825-30
   PubMed Web of Science ®Google Scholar
• Reasor MJ, Hastings KL, Ulrich RG. Drug-induced phospholipidosis: issues and future directions. Expert Opin Drug Saf 2006;5:567-83
   PubMed Web of Science ®Google Scholar
• Ploemen JHTM, Kelder J, Hafmans T, Use of physicochemical calculation of pKa and ClogP to predict phospholipidosis-inducing potential: a case study with structurally realted piperazines. Exp Toxicol Pathol 2004;55:347-55
   PubMed Web of Science ®Google Scholar
• Przybylak KR, Cronin MTD. In silico studies of the relationship between chemical structure and drug induced phospholipidosis. Mol Inform 2011; In press
   Web of Science ®Google Scholar
• Worth A, Cronin MTD. The use of pH measurements to predict the potentail of chemicals to cause acute dermal and ocular toxicity. Toxicology 2001;169:119-31
   PubMed Web of Science ®Google Scholar
• Welss T, Basketter DA, Schroder KR. In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Toxicol in Vitro 2004;18:231-43
   PubMed Web of Science ®Google Scholar
• Kazius J, Nijssen S, Kok J, Substructure mining using elaborate chemical representations. J Chem Inf Model 2006;46:597-605
   PubMed Web of Science ®Google Scholar
• Klopman G. MULTICASE: 1. A hierarchical computer automated structure evaluation program. Quant Struct Act Release 1992;11:176-84
   Web of Science ®Google Scholar
• Klopman G, Rosenkranz HS. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE. Mutat Res 1994;305:33-46
   PubMed Web of Science ®Google Scholar
• Saiakhov RD, Klopman G. MultiCASE expert systems and the REACH initiative. Toxicol Mech Methods 2008;18:159-75
   PubMed Web of Science ®Google Scholar
• Snyder RD, Pearl GS, Mandakas G, Assessment of sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules. Environ Mol Mutagen 2004;43:143-58
   PubMed Web of Science ®Google Scholar
• Kazius J, McGuire R, Bursi R. Derivation and validation of toxicophores for mutagenicity prediction. J Med Chem 2005;48:312-20
   PubMed Web of Science ®Google Scholar
• Gubbels-van Hal WMLG, Blaauboer BJ, Barentsen HM, An alternative approach for the safety evaluation of new ans existing chemicals, an exercise in integrated testing. Regul Toxicol Pharmacol 2005;42:284-95
   PubMed Web of Science ®Google Scholar
• Enoch SJ. Chemical category formation and read-across for the prediction of toxicity. In: Puzyn T, Leszczynski J, Cronin MTD, editors. Recent Advances in QSAR Studies: Methods an Applications. Springer; London: 2010
   Google Scholar
• Dimitrov S, Mekenyan O. An introduction to read-across for the prediction of the effects of chemicals. In: Cronin MTD, Madden JC, editors. In Silico Toxicology. RSC; Cambridge: 2010
   Google Scholar
• Faed EM. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab Rev 1984;15:1213-49
   PubMed Web of Science ®Google Scholar
• Mostrag-Szlichtyng A, Comenges JMZ, Worth AP. Computational toxicology at the European Commission's Joint Research Centre. Expert Opin Drug Metab 2010;6:785-92
   PubMed Web of Science ®Google Scholar
• Giri S, Nieber K, Bader A. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages. Expert Opin Drug Metab 2010;6:895-917
   PubMed Web of Science ®Google Scholar
• Dong JQ, Liu J, Smith PC. Role of benoxaprofen and flunoxaprofen acyl glucurides in covalent binding to rat plasma and liver proteins in vivo. Biochem Pharmacol 2005;70:937-48
   PubMed Web of Science ®Google Scholar
• Nelson SD. Molecular mechanisms of adverse drug reactions. Curr Ther Res 2001;62:885-99
   Web of Science ®Google Scholar
• Gomez-Lechon MJ, Lahoz A, Gombau L, In vitro evaluation of potential hepatotoxicity induced by drugs. Curr Pharm Des 2010;16:1963-77
   PubMed Web of Science ®Google Scholar
• Greene N, Fisk L, Naven RT, Developing structure-activity relationships for the prediction of hepatotoxicity. Chem Res Toxicol 2010;23:1215-22
   PubMed Web of Science ®Google Scholar
• Kalgutkar AS, Dalvie DK, Aubrecht J, Genotoxicity of 2-(3-chhlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation. Drug Metab Dispos 2007;35:848-58
   PubMed Web of Science ®Google Scholar
• Hansch C, Zhang L. Comparative QSAR: radical toxicity and scavenging. Two different sides of the same coin. SAR QSAR Environ Res 1995;4:73-82
   PubMedGoogle Scholar
• Walsh JS, Miwa GT. Bioactivation of drugs: risk and drug design. Annu Rev Pharmacol 2011;51:145-67
   Google Scholar
• Reasor MJ, Kacew S. Drug-induced phospholipidosis: are there functional consequences? Exp Biol Med 2001;226:825-30
   PubMed Web of Science ®Google Scholar
• Kaloyanides GJ, Pastoriza-Munoz E. Animoglycoside nephrotoxicity. Kidney Int 1980;18:571-82
   PubMed Web of Science ®Google Scholar
• Laurent G, Kishore BK, Tulkens PM. Animoglycoside-induced phospholipidosis and nephrotoxicity. Biochem Pharmacol 1990;40:2383-92
   PubMed Web of Science ®Google Scholar
• Dykens JA, Will Y. The significance of mitochondrial toxicity testing in drug development. Drug Discov Today 2007;12:777-85
   PubMed Web of Science ®Google Scholar
• Schwobel JAH, Wondrousch D, Koleva YK, Prediction of Michael-type acceptor reactivity toward glutathione. Chem Res Toxicol 2010;23:1576-85
   PubMed Web of Science ®Google Scholar
• For further information about the eTox project see. Available from: www.etoxproject.eu
   Google Scholar